Dubowitz syndrome: common findings and peculiar urine odor
Received 8 May 2013
Accepted for publication 27 June 2013
Published 8 October 2013 Volume 2013:6 Pages 87—90
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Cynthia Chehade,1 Johnny Awwad,2 Nadine Yazbeck,1 Marianne Majdalani,1 Rima Wakim,1 Hala Tfayli,1 Chantal Farra1,3
1Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon; 2Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon; 3Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Background: Dubowitz syndrome is a rare, autosomal recessive disorder characterized by intrauterine and postnatal growth retardation, severe microcephaly, psychomotor retardation, hyperactivity, eczema, and characteristic dysmorphic facial features. Although many cases have been reported, the cause of this disease is still unknown.
Case: We present here the case of a Lebanese girl with Dubowitz syndrome in whom an unpleasant urine odor was persistently reported since birth.
Conclusion: Although Dubowitz syndrome has been largely described in the medical literature, this is the first time that a peculiar urine odor was reported. This case report adds a new and unusual feature to the numerous findings related to this rare polymorphous syndrome.
Keywords: Dubowitz syndrome, autosomal recessive, developmental delay, odorous urine
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.